Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Nobel prize for physiology or medicine 2011
- Protein wins Noble prize twice!
- Nobel prize for physiology or medicine 1995
- Toll!
- The mouldy fly (1)
- Toll and Toll-like receptors
- Inflammation
- Inflammation is at the heart of modern medicine
- Why does inflammation lie at the heart of disease?
- Innate immunity: an explosion of new information
- Edward Jenner: vaccination, 1798
- 1980s+: focus on the Ag
- Evolution and revolution in immunology (1)
- Evolution and revolution in immunology (2)
- 2 parts to the pathogen
- The mouldy fly (2)
- LPS responsiveness in mice
- 7 families of PRRs
- Homeostasis: prototypical sensors and restorers
- Contact dermatitis
- TLRs in disease: antagonism
- Endogenous ligands (DAMPs) for TLR4 in RA
- Resurgence of interest in IL-1
- Inflammasomes
- NLRs: a large family in all metazoan life
- How NLRs are activated
- Nlrp3 in disease
- TLRs, NLRs, Nalp3 and IL-1
- IL1 in type 2 diabetes (T2D)
- Nalp3-deficient mice are hyper-sensitive to insulin
- What activates Nlrp3 in T2D?
- IAPP and type 2 diabetes
- IAPP oligomerization
- The bad: IAPP fibrils
- Production of IL-1b by IAPP requires Nlrp3
- A model for the pathogenesis of T2D
- Potential inflammasome associated diseases
- Inflammasome and arthritic diseases
- TLRs, miRNAs and inflammatory diseases
- Future perspectives
Topics Covered
- Innate immunity
- Principles and processes
- PAMPs and PRRs
- Discovery of Toll-like receptors (TLRs)
- Role of TLRs in innate immunity
- Other innate receptors
- NLRs, RLRs, CLRs
- Signaling pathways
- Roles in inflammatory and infectious diseases
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
O'Neill, L. (2012, April 3). TLRs, NLRs, DAMPs and PAMPs [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/FKYE1580.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Luke O'Neill has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Immunology & Inflammation
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Luke O'Neill.
I am Professor of Biochemistry
in the Trinity Biomedical
Sciences Institute,
part of the School
of Biochemistry and Immunology.
So what I'm going to be
telling you all about
is a family of receptors
called the toll-like receptors,
and then I'm also going to
tell you about related innate
immune receptor systems,
because this area
has undergone a major explosion of
information in the past 10 years or so.
And a discovery of these
receptors has greatly helped
our understanding of
innate immunity and also
of the inflammatory process.
And there's lots of insights
coming out of this research
into diseases like arthritis,
metabolic diseases like diabetes,
atherosclerosis.
And really, many people
see these discoveries
as being the most important
in the past 10 years
or so in the whole
field of immunology.
0:45
Now, this area, of course, is
extremely important for medicine
and that can be seen in the
award in 2011 of the Nobel
Prize for Physiology or Medicine
for the area of innate immunity,
and these three scientists,
Bruce Beutler, Jules Hoffmann,
and Ralph Steinman, were
given this great honor.
And everybody in the
field of immunology
is delighted to see this honor being
given because their discoveries,
as I say, really have had a huge
influence on the whole field
of immunology and also the
basis for many diseases,
including inflammatory diseases.
And what Bruce Beutler
and Jules Hoffman won for
was effectively discovering
the toll-like receptor system.
Jules in particular found
toll in the fruit fly,
and his lab discovered
this as having
a key role in anti-fungal
community in the fly.
And then Bruce Beutler
found the mammalian system
of toll-like receptors, in
particular that toll-like number
four can sense a product called
lipopolysaccharide or LPS,
from gram negative bacteria.
And this is a big step up in
our understanding about how
the immune system senses bacteria.
And then thirdly, Ralph
Steinman, he won the Nobel Prize
for discovering dendritic cells.
And these are the key front
line cells in innate immunity.
And they also become activated and
then trigger adaptive immunity.
So in many ways, the three
of them combined, then,
reflect these recent discoveries
in the area of toll-like receptors
and innate immunity.